Vaxcyte, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Vaxcyte, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Cantor Global Healthcare Conference 2025

Sep 3, 2025

Transcript

Q2 2025

Aug 6, 2025

Quarterly report10-Q

Earnings release8-K

Q1 2025

May 7, 2025

Earnings release8-K

Quarterly report10-Q

Investor Presentation

May 7, 2025

Slides

Study Result

Mar 31, 2025

Slides

Press release

Guggenheim SMID Cap Biotech Conference

Feb 6, 2025

Transcript

2024

Q4 2024

Feb 25, 2025

Transcript

Slides

Annual report10-K

Earnings release8-K

Q3 2024

Nov 5, 2024

Quarterly report10-Q

Earnings release8-K

Study Result

Sep 3, 2024

Slides

Q2 2024

Aug 6, 2024

Quarterly report10-Q

Earnings release8-K

Investor Presentation

May 10, 2024

Slides

Q1 2024

May 8, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 27, 2024

Annual report10-K

Slides

Earnings release8-K

Investor Presentation

Nov 9, 2023

Slides

Q3 2023

Nov 6, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 8, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 8, 2023

Quarterly report10-Q

Earnings release8-K

Investor Presentation

May 8, 2023

Slides

Study Result

Apr 17, 2023

Press release

Slides

Corporate Presentation

Apr 17, 2023

Slides

2022

Q4 2022

Feb 27, 2023

Annual report10-K

Earnings release8-K

2021

Q4 2021

Feb 28, 2022

Annual report10-K

2020

Q4 2020

Mar 29, 2021

Annual report10-K